Virginia · 2025 Regular Session · Bill

HB 1724: Prescription Drug Affordability Board; established, drug cost affordability review, report.

Vetoed Last action April 2, 2025: House sustained Governor's veto

Plain-language summary

HB 1724 is a bill introduced in the Virginia House on January 4, 2025. According to its official title, it concerns: Prescription Drug Affordability Board; established, drug cost affordability review, report. Primary sponsor: Karrie Delaney (Democratic). It lists 8 additional sponsors. Most recent recorded action (April 2, 2025): House sustained Governor's veto.

Sponsors

Primary sponsor: Karrie Delaney (Democratic). 8 co-sponsors.